Related Experiment Videos
Endotoxin-induced tumor necrosis factor
Summary
Researchers discovered tumor necrosis factor (TNF) in BCG-infected mice treated with endotoxin. This host-released factor, TNF, causes tumor necrosis and is toxic to cancer cells in vitro.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Endotoxin administration to BCG-infected mice induces a serum factor with tumor-necrotizing properties.
- This factor, termed tumor necrosis factor (TNF), mimics endotoxin's effects but is host-derived.
Purpose of the Study:
- To characterize the nature and properties of the newly identified tumor necrosis factor (TNF).
- To investigate the selective toxicity of TNF towards neoplastic cells.
Main Methods:
- Induction of TNF in mice, rats, and rabbits via BCG infection and endotoxin treatment.
- In vitro assays to assess TNF's cytotoxicity against various cell lines, including neoplastic and normal cells.
- Biochemical analysis to determine TNF's molecular weight and composition.
Main Results:
- TNF was identified as a glycoprotein with a molecular weight under 70,000.
- TNF demonstrated selective toxicity, causing necrosis of transplanted murine tumors and in vitro cytotoxicity against murine and human cancer cell lines.
- TNF did not exhibit toxicity towards mouse embryo cultures.
- TNF exhibited distinct in vitro immunomodulatory effects, some similar to and others different from endotoxin.
Conclusions:
- Tumor necrosis factor (TNF) is a host-derived mediator responsible for endotoxin-induced tumor necrosis.
- TNF possesses selective cytotoxic activity against cancer cells, making it a potential therapeutic agent.
- Further research into TNF's immunomodulatory functions is warranted.